← Back to headlines
Experts estimate this US biotech stock has 100 percent potential, one even 250 percent [premium]
Developers of medical active ingredients often have a long road ahead until a preparation is approved. This company has several in the pipeline.
7 Mar, 15:03 — 7 Mar, 15:03
